Evidence map›Paper›PMID 34943426›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Prognostic Role of 2-[

Domenico Albano, Francesco Dondi, Angelica Mazzoletti, Pietro Bellini, Carlo Rodella, Francesco Bertagna

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. The Role ofMedical sciences (Basel, Switzerland) · 2026
    Review
  6. The utility of quantitativeAsia Oceania journal of nuclear medicine & biology · 2025
    Article
  7. Clinico-pathological factors and [BMC medical imaging · 2024
    Article
  8. Review
  9. Article
  10. Role of [Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Review
  11. Review
  12. Review
  13. How [Cancers · 2024
    Article
  14. [European radiology · 2023
    Article
  15. Review
  16. Article
  17. Could [Diagnostics (Basel, Switzerland) · 2022
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Domenico AlbanoNuclear Medicine, University of Brescia and ASST Spedali Civili Brescia, 25123 Brescia, Italy.ORCID 0000-0003-0810-6494
Francesco DondiNuclear Medicine, University of Brescia and ASST Spedali Civili Brescia, 25123 Brescia, Italy.
Angelica MazzolettiNuclear Medicine, University of Brescia and ASST Spedali Civili Brescia, 25123 Brescia, Italy.
Pietro BelliniNuclear Medicine, University of Brescia and ASST Spedali Civili Brescia, 25123 Brescia, Italy.
Carlo RodellaHealth Physics Department, ASST-Spedali Civili, 25123 Brescia, Italy.
Francesco BertagnaNuclear Medicine, University of Brescia and ASST Spedali Civili Brescia, 25123 Brescia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical and prognostic role of 2-deoxy-2-[

Indexed as

2-[18F]FDG PET/CTDTCMTVthyroid cancerTLG

Identifiers

PMID34943426
PMCPMC8700137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.